Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Nanovibronix Inc
(NQ:
NAOV
)
0.7500
-0.0200 (-2.60%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Nanovibronix Inc
< Previous
1
2
3
Next >
NanoVibronix Issues Letter to Stockholders
April 09, 2024
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield
March 28, 2024
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Featured in Your Bladder Health Magazine
December 06, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity
December 04, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan
November 28, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Regains Nasdaq Compliance
November 21, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Issues Letter to Shareholders
November 14, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix UroShield Products Available on NHS Drug Tariff Effective November 1
November 07, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services’ Drug Tariff
September 27, 2023
From
NanoVibronix, Inc.
Via
Business Wire
BioMedNewsBreaks – IBN’s BioMedWire Highlights NanoVibronix Inc.’s (NASDAQ: NAOV) $5M Private Placement
September 21, 2023
Via
Investor Brand Network
NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meeting
September 06, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
August 30, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Inc. (NASDAQ: NAOV) is One of Wednesday Morning’s Most Active Stocks
August 30, 2023
Via
Investor Brand Network
NanoVibronix Cites Positive Results from Independent Testing of UroShield
August 30, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Responds to CMS’ Determination for PainShield
August 29, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Applies for Inclusion of UroShield Products in NHS Prescription Services’ Drug Tariff
August 28, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield Plus
August 23, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces Distribution Agreement with Sports Medicine Supplier Mio-Guard
June 14, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Issues Letter to Shareholders
May 18, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Issues Letter to Shareholders
April 18, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Receives Positive Final Results of Independent Lifecycle Testing of PainShield Prompted by Centers for Medicare and Medicaid Services (CMS)
March 28, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Files Provisional U.S. Patent Application for UroShield Ultra
March 21, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces Positive Results from Independent Product Trial of UroShield for Patients with a Spinal Cord Injury
March 14, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Regains Nasdaq Compliance
March 03, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix to Launch Rental Program for PainShield and UroShield
February 22, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces Reverse Stock Split
February 08, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Provides Update on Expanding Access to PainShield
January 18, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces Results of Annual Meeting of Stockholders Held Today
December 15, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces Partnership with Peak Medical, Ltd.
December 13, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces Closing of $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
December 01, 2022
From
NanoVibronix, Inc.
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.